BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33830189)

  • 1. Charcot-Leyden crystals in chronic eosinophilic leukemia.
    Sandberg Y; Weerkamp F
    Blood; 2021 Apr; 137(14):1985. PubMed ID: 33830189
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic eosinophilic leukemia presenting with autoimmune hemolytic anemia and erythrophagocytosis by eosinophils.
    Kuk JS; Maceachern JA; Soamboonsrup P; McFarlane A; Benger A; Patterson W; Yang L; Trus MR
    Am J Hematol; 2006 Jun; 81(6):458-61. PubMed ID: 16680737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of eosinophilic disorder that evolved in acute lymphoblastyc leukemia.
    Schiavinato A; Piva E; Pantano G; Cornoldi P; Nabergoj M; Plebani M
    Am J Hematol; 2016 Jan; 91(1):167-8. PubMed ID: 25963539
    [No Abstract]   [Full Text] [Related]  

  • 4. Charcot-Leyden crystals within a periapical lesion.
    Silver GK; Simon JH
    J Endod; 2000 Nov; 26(11):679-81. PubMed ID: 11469301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of Charcot-Leyden crystals in eosinophilic cystitis.
    Staribratova D; Belovejdov V; Staikov D; Dikov D
    Arch Pathol Lab Med; 2010 Oct; 134(10):1420. PubMed ID: 20923292
    [No Abstract]   [Full Text] [Related]  

  • 6. Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: a fluorescence in situ hybridization study.
    Ma SK; Wong KF; Chan JK; Kwong YL
    Br J Haematol; 1995 May; 90(1):216-8. PubMed ID: 7786789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charcot-Leyden crystals in acute myeloid leukemia.
    van de Kerkhof D; Scharnhorst V; Huysentruyt CJ; Brands-Nijenhuis AV; Ermens AA
    Int J Lab Hematol; 2015 Aug; 37(4):e100-2. PubMed ID: 25754678
    [No Abstract]   [Full Text] [Related]  

  • 8. Charcot-Leyden crystals in fine needle aspiration cytology.
    Arora VK; Singh N; Bhatia A
    Acta Cytol; 1997; 41(2):409-12. PubMed ID: 9100774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charcot-Leyden crystals.
    Grigoriadis G; Anderson MA; Whitehead S
    Intern Med J; 2010 Nov; 40(11):792. PubMed ID: 21155159
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of Charcot Leyden crystals in liver cytology-A case report.
    Thakral D; Agarwal P; Saran RK; Saluja S
    Diagn Cytopathol; 2015 May; 43(5):392-4. PubMed ID: 25350873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) to intracytoplasmic crystals in tumor cells of primary solid and papillary epithelial neoplasm of the pancreas.
    Dvorak AM; Letourneau L; Weller PF; Ackerman SJ
    Lab Invest; 1990 May; 62(5):608-15. PubMed ID: 2160563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic leukemia associated with t(2;5)(p23;q31).
    Lepretre S; Jardin F; Buchonnet G; Lenain P; Stamatoullas A; Kupfer I; Courville P; Callat MP; Contentin N; Bastard C; Tilly H
    Cancer Genet Cytogenet; 2002 Mar; 133(2):164-7. PubMed ID: 11943346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A third case of chronic eosinophilic leukemia with the (8;9)(p23;p24) translocation.
    Cornfield DB; Gheith SM; Friedman EL
    Cancer Genet Cytogenet; 2008 Aug; 185(1):60-1. PubMed ID: 18656698
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome.
    Dvorak AM; Weller PF; Monahan-Earley RA; Letourneau L; Ackerman SJ
    Lab Invest; 1990 May; 62(5):590-607. PubMed ID: 2160562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals.
    Weller PF; Goetzl EJ; Austen KF
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7440-3. PubMed ID: 6261258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic.
    Morsia E; Reichard K; Pardanani A; Tefferi A; Gangat N
    Am J Hematol; 2020 Jul; 95(7):E172-E174. PubMed ID: 32243620
    [No Abstract]   [Full Text] [Related]  

  • 17. Charcot-Leyden crystals in the trephine biopsy of a patient with a FIP1L1-PDGFRA - positive myeloproliferative disorder.
    Lyall H; O'Connor S; Clark D
    Br J Haematol; 2007 Aug; 138(4):405. PubMed ID: 17593250
    [No Abstract]   [Full Text] [Related]  

  • 18. Charcot-Leyden crystals and bone marrow necrosis in acute myeloid leukemia.
    Radujkovic A; Bellos F; Andrulis M; Ho AD; Hundemer M
    Eur J Haematol; 2011 May; 86(5):451-2. PubMed ID: 21342270
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinicopathologic studies of 13 cases of chronic eosinophilic leukemia].
    Wang W; Chen HS; Liu EB; Yang QY; Fang LH; Sun FJ; Qian LS
    Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):259-63. PubMed ID: 18844036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia with Charcot-Leyden crystals.
    Manny JS; Ellis LR
    Blood; 2012 Jul; 120(3):503. PubMed ID: 22993791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.